@dansfera: Many clinical trial sites are flying dangerously close to the edge of non-compliance without even realizing it. The fix isn't necessarily complex, but it requires a strict separation of business operations from clinical functions. One critical misstep? Allowing the Principal Investigator to take on a consultant role or linking their agreements to specific incentives. These simple shifts in structure are often the difference between a compliant site and a major regulatory headache. #clinicaltrials #regulatorycompliance #biotech #clinicalresearch #medicalnews